Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$44,768,229
+$13,571,404 QoQ
Shares Held
769,875
+10.6% QoQ
Ownership
0.796%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 95.87387562916058.ToString("F0")%
Shared 0.ToString("F0")%
None 4.126124370839422.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. XENE ranks #57 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in XENE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,768,229 | 769,875 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $31,196,825 | 696,047 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $28,934,457 | 720,659 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,584,338 | 561,800 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,853,658 | 442,732 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $16,081,642 | 410,246 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $18,095,434 | 459,625 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,199,104 | 364,173 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $12,905,270 | 299,774 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,332,469 | 376,302 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $8,723,370 | 255,368 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $10,590,580 | 275,080 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $10,215,289 | 285,423 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $11,180,021 | 283,541 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $16,796,066 | 465,265 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $9,013,871 | 296,314 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $22,142,981 | 724,337 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,354,348 | 171,394 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,466,650 | 95,985 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,834,299 | 152,218 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,420,420 | 135,219 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,121,840 | 137,961 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $685,963 | 61,966 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $367,070 | 29,272 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||